In today’s clinical trials, compared to those of the past, there is increasing complexity, greater data collection, and a ...

The global clinical trials market has emerged as a vital cornerstone of the healthcare sector, driven by an ever-increasing ...

Teams must work together with technology solutions and optimize integration to unlock their full potential. Clinical trials ...

Market is on a rapid growth trajectory, poised to expand from USD 4.08 billion in 2024 to USD 10.35 billion by 2033, at a CAGR of 10.9% during the forecast period 2025–2033. This remarkable growth is ...

The potential applications of artificial intelligence (AI) in biopharmaceuticals appear wide-ranging and transformative.

On January 6, 2025, the US Food and Drug Administration (FDA) and the US Department of Health and Human Services (HHS) Office for Human ...

Researchers determined further improvements are necessary to better capture clinically useful data in a pediatric population for DOAC trials.

Potential Medicare coverage reforms, such as eliminating Coverage with Evidence Development, would remove key policy tools ...

Multiracial growth impacts clinical trials. Explore challenges in race classification, health disparities, and genomic profiling.

Company Achieves Key Clinical Milestone with more than 20 Patients Enrolled in Weekly Dosing Cohort of Phase 1 Trial of Decoy20Pharmacodynamic ...